| Customization: | Available |
|---|---|
| Certification: | ISO |
| Assay Method: | HPLC |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Aescin is a three-terpene compounds, which including Aescin A, B, C, D. and Aescin A and Aescin B are known as escin beta-escin, while Aescin C and Aescin D are called alpha-escin. Alpha-escin and beta-escin are two isomers of Aescin. Although two melting point, optical rotation, hemolytic index and water solubility of two Aescin are not the same, they are not much different effect.
| Product Name | Aescin |
| Molecular Formula | C55H86O24 |
| Molecular Weight | 1131.26 |
| CAS | 6805-41-0 |
Aescin is the major active principle from the horse chestnut tree and is claimed to have clinical activity in venous insufficiency. Investigations in animal models suggest that it has antioedematous, anti-inflammatory, and venotonic properties. Clinical tolerance is usually excellent.
1.Repair damaged skin, highly moisturizing and rich in flavonoids, with a strong natural anti-aging and anti-wrinkle effect, can improve the blood circulation of some eye skin, and can also eliminate cellulite, dark circles and eye bags have some effect.
2.Aescinin can resist tissue edema, reduce vascular permeability, prevent water accumulation in tissues, and quickly eliminate the heavy feeling and pressure caused by local edema.
3.Aescinin has a wide range of pharmacological activities, including anti-inflammatory and anti-edema, enhancing venous tension, inhibiting gastric acid secretion, scavenging reactive oxygen species, and resisting liver injury.
1.As raw material of antiedema, relieving pain, easing the pressure, it is used in pharmaceutical field.
2.As the product of removing edema, antifatigue and easing the pressure, it is used in health indus.
3.Applied in the field of cosmetics, anti-aging anti-wrinkle effect.
Keywords: blunt trauma, chronic venous insufficiency, edema, escin, pain, Reparil
* The statements in this section have not been evaluated by the FDA or EFSA.
){kind=link}